SOPHARMA AD - Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Donev investments holding_Sopharma_EN_2024.09.18Buy.pdfNotification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 100 / 2024

Date of issue: 2024-09-19

Short name of the issuer

SOPHARMA AD

Subject

Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Annexes

File Description

Donev investments holding_Sopharma_EN_2024.09.18Buy.pdfDonev investments holding_Sopharma_EN_2024.09.18Buy.pdf Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-09-19 Ognian Donev Executive Director